$1.27
+0.06
(+4.96%)▲
Insights on Kronos Bio Inc
In the last 1 year, Seagen, Inc. has given 80.8% return, outperforming this stock by 107.8%
In the last 3 years, Novo Nordisk A/s has given 20.4% return, outperforming this stock by 116.4%
8.61%
Downside
Day's Volatility :10.71%
Upside
2.3%
42.44%
Downside
52 Weeks Volatility :74.26%
Upside
55.28%
Period | Kronos Bio Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 0.79% | 0.0% | 0.0% |
6 Months | -23.49% | 2.2% | 0.0% |
1 Year | -27.01% | -4.7% | -2.1% |
3 Years | -95.98% | 18.0% | -6.5% |
Market Capitalization | 70.0M |
Book Value | $3.07 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -2.08 |
Wall Street Target Price | 8.75 |
Profit Margin | 0.0% |
Operating Margin TTM | -3688.66% |
Return On Assets TTM | -28.83% |
Return On Equity TTM | -53.39% |
Revenue TTM | 4.0M |
Revenue Per Share TTM | 0.07 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -125.9M |
Diluted Eps TTM | -2.08 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -2.03 |
EPS Estimate Next Year | -1.9 |
EPS Estimate Current Quarter | -0.51 |
EPS Estimate Next Quarter | -0.54 |
What analysts predicted
Upside of 588.98%
Sell
Neutral
Buy
Kronos Bio Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Kronos Bio Inc | 48.04% | -23.49% | -27.01% | -95.98% | -95.31% |
![]() Moderna, Inc. | 9.42% | -35.83% | -54.97% | -49.47% | 333.33% |
![]() Regeneron Pharmaceuticals, Inc. | 0.6% | 13.15% | 9.35% | 68.7% | 124.16% |
![]() Novo Nordisk A/s | -4.03% | 23.9% | 55.84% | 186.15% | 330.1% |
![]() Seagen, Inc. | 0.86% | 10.81% | 80.8% | 20.4% | 259.73% |
![]() Vertex Pharmaceuticals Incorporated | -6.55% | 8.87% | 11.3% | 55.67% | 105.25% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Kronos Bio Inc | NA | NA | NA | -2.03 | -0.53 | -0.29 | 0.0 | 3.07 |
![]() Moderna, Inc. | 24.73 | NA | 0.0 | -12.72 | -0.22 | -0.07 | 0.0 | 35.32 |
![]() Regeneron Pharmaceuticals, Inc. | 23.18 | 23.18 | 1.75 | 42.5 | 0.17 | 0.09 | 0.01 | 234.47 |
![]() Novo Nordisk A/s | 41.18 | 41.18 | 4.02 | 2.67 | 0.89 | 0.22 | 0.01 | 20.77 |
![]() Seagen, Inc. | NA | NA | 18.53 | -4.16 | -0.28 | -0.13 | 0.03 | 13.52 |
![]() Vertex Pharmaceuticals Incorporated | 26.38 | 26.38 | 0.5 | 15.04 | 0.23 | 0.14 | 0.0 | 64.05 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Kronos Bio Inc | Buy | $70.0M | -95.31% | NA | 0.0% |
![]() Moderna, Inc. | Buy | $30.4B | 333.33% | 24.73 | -38.0% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $88.5B | 124.16% | 23.18 | 30.47% |
![]() Novo Nordisk A/s | Buy | $459.0B | 330.1% | 41.18 | 35.11% |
![]() Seagen, Inc. | Hold | $40.2B | 259.73% | NA | -32.61% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $90.5B | 105.25% | 26.38 | 35.94% |
Omega Fund Management LLC
Bvf Inc
Vida Ventures Advisors, LLC
Perceptive Advisors LLC
Vanguard Group Inc
PARTNERS CAPITAL INVESTMENT GROUP, LLP
Kronos Bio Inc’s price-to-earnings ratio stands at None
Read Morekronos bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. leveraging industry-leading research into high-throughput screening strategies for chemical modulators of transcription factors and other challenging targets in oncology, kronos utilizes its small molecule microarray (smm) platform and extensive know-how in biological assay development to pursue novel therapies against some of the most important and intractable targets in cancer research.
Organization | Kronos Bio Inc |
Employees | 99 |
CEO | Dr. Norbert W. Bischofberger Ph.D. |
Industry | Health Technology |
Asymmetric Smart Alpha S&p 500 Etf
$1.27
+4.96%
Advisorshares Alpha Dna Equity Sentiment Etf
$1.27
+4.96%
Falcon's Beyond Global Inc
$1.27
+4.96%
Jaguar Global Growth Corporation I
$1.27
+4.96%
Missfresh Ltd
$1.27
+4.96%
Shuaa Partners Acquisition Corp I
$1.27
+4.96%
Rose Hill Acquisition Corp
$1.27
+4.96%
Partners Bancorp
$1.27
+4.96%
Mercantile Bank Corp
$1.27
+4.96%